352 related articles for article (PubMed ID: 9427805)
1. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
[TBL] [Abstract][Full Text] [Related]
2. Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma.
Maier T; Holda JH
J Immunol; 1987 Jun; 138(12):4075-84. PubMed ID: 2953798
[TBL] [Abstract][Full Text] [Related]
3. Murine natural suppressor cells in the newborn, in bone marrow, and after cyclophosphamide. Genetic variations and dependence on IFN-gamma.
Maier T; Holda JH; Claman HN
J Immunol; 1989 Jul; 143(2):491-8. PubMed ID: 2525587
[TBL] [Abstract][Full Text] [Related]
4. Natural suppressor activity in graft-vs-host spleen and normal bone marrow is augmented by IL 2 and interferon-gamma.
Holda JH; Maier T; Claman HN
J Immunol; 1986 Dec; 137(11):3538-43. PubMed ID: 2946763
[TBL] [Abstract][Full Text] [Related]
5. The selective growth of murine newborn-derived suppressor cells and their probable mode of action.
Jadus MR; Parkman R
J Immunol; 1986 Feb; 136(3):783-92. PubMed ID: 2934478
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor cell proliferation by natural suppressor cells present in murine bone marrow.
Sugiura K; Inaba M; Ogata H; Yasumuzu R; Sardiña EE; Inaba K; Kuma S; Good RA; Ikehara S
Cancer Res; 1990 May; 50(9):2582-6. PubMed ID: 2139355
[TBL] [Abstract][Full Text] [Related]
7. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
Chiba K; Nishimura T; Hashimoto Y
J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
[TBL] [Abstract][Full Text] [Related]
8. T cell regulation of interferon-alpha/beta (IFN-alpha/beta) production by alloantigen-stimulated bone marrow cells.
Reyes VE; Klimpel KD; Klimpel GR
J Immunol; 1985 May; 134(5):3137-41. PubMed ID: 2858508
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to interferon-gamma inhibit interleukin 2-dependent induction of growth and maturation in lectin/antigen-reactive cytolytic T lymphocyte precursors.
Simon MM; Hochgeschwender U; Brugger U; Landolfo S
J Immunol; 1986 Apr; 136(8):2755-62. PubMed ID: 3082972
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
[TBL] [Abstract][Full Text] [Related]
11. Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis.
Young MR; Wright MA
Cancer Res; 1992 Nov; 52(22):6335-40. PubMed ID: 1423279
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway.
Albina JE; Abate JA; Henry WL
J Immunol; 1991 Jul; 147(1):144-8. PubMed ID: 1904899
[TBL] [Abstract][Full Text] [Related]
13. The effect of recombinant murine interferon-gamma on the hematopoietic and immunological parameters of mice bearing metastatic Lewis lung carcinoma tumors.
Young MR; Young ME; Wepsic HT
Exp Hematol; 1988 May; 16(4):295-301. PubMed ID: 2966070
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of the generation of T suppressor cells of contact sensitivity in vitro by interferon.
Knop J; Taborski B; DeMaeyer-Guignard J
J Immunol; 1987 Jun; 138(11):3684-7. PubMed ID: 2953787
[TBL] [Abstract][Full Text] [Related]
15. Role of lymphokine-activated killer cells as mediators of veto and natural suppression.
Azuma E; Kaplan J
J Immunol; 1988 Oct; 141(8):2601-6. PubMed ID: 3171179
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mouse alpha/beta-interferon of the multiplication of alpha/beta-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes.
Yasui H; Proietti E; Vignaux F; Eid P; Gresser I
Cancer Res; 1990 Jun; 50(12):3533-9. PubMed ID: 2140290
[TBL] [Abstract][Full Text] [Related]
17. Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.
Orosz CG; Zinn NE; Olsen RG; Mathes LE
J Immunol; 1985 May; 134(5):3396-403. PubMed ID: 2984289
[TBL] [Abstract][Full Text] [Related]
18. Early B cell precursors in long-term bone marrow culture: selective development in the bone marrow of irradiated recipients.
Nishikawa S; Kina T; Amagai T; Katsura Y
Eur J Immunol; 1985 Jul; 15(7):696-701. PubMed ID: 3159587
[TBL] [Abstract][Full Text] [Related]
19. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
[TBL] [Abstract][Full Text] [Related]
20. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.
Nelson BJ; Ralph P; Green SJ; Nacy CA
J Immunol; 1991 Mar; 146(6):1849-57. PubMed ID: 1900875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
